Practical vs Recent Clinical Trial Use Of Dalbavancin

This quality improvement study compares demographic characteristics and clinical outcomes among patients treated with dalbavancin for bacteremia in clinical practice vs a randomized clinical trial.

Corresponding Author: Jasmine R. Marcelin, MD, Division of Infectious Diseases, Department of Internal Medicine, College of Medicine, University of Nebraska Medical Center, 985400 Nebraska Medical Center, Omaha, NE 68198-5400 (jasmine.marcelin@unmc.edu).

Link to the article in your story

We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)

Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Need more information? Contact us.